AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 239: E317-E321, 1980;
0193-1849/80 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Douglas, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Douglas, J. G.

AJP - Endocrinology and Metabolism, Vol 239, Issue 5 317-E321, Copyright © 1980 by American Physiological Society


ARTICLES

Potassium ion as a regulator of adrenal angiotensin II receptors

J. G. Douglas

The importance of potassium as a regulator of angiotensin II receptors of two target tissues has been investigated by combining high-K+ diet in rats with a converting enzyme inhibitor (Captopril; SQ 14,225) or angiotensin II. K+ loading alone produced the characteristic increase in Ka and decrease in number of smooth muscle receptors and decrease in Ka and increase in number of adrenal receptors. The combination of Captopril and high-K+ diet blocked the development of most of these effects. In smooth muscle, the number of angiotensin II receptors was 40% higher (n = 5) and Ka was 94% lower (n = 5); in the adrenal the Ka was 29% higher (n = 4) than with K+ loading alone. However, development of the increment in number of adrenal receptors occurred in spite of Captopril treatment. In addition, angiotensin II infusion concomitantly with high-K+ diet resulted in a further increment in the number of adrenal receptors. These studies represent the first example of an ion as a regulator of a peptide hormone receptor and emphasize that different mechanisms of regulation are involved in adrenal and smooth muscle.


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
A. SPAT and L. HUNYADY
Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways
Physiol Rev, April 1, 2004; 84(2): 489 - 539.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. G. H. van der Kleij, P. E. de Jong, R. H. Henning, D. de Zeeuw, and G. Navis
Enhanced Responses of Blood Pressure, Renal Function, and Aldosterone to Angiotensin I in the DD Genotype Are Blunted by Low Sodium Intake
J. Am. Soc. Nephrol., April 1, 2002; 13(4): 1025 - 1033.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online